International Biotechnology (LON:IBT) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Shares of International Biotechnology (LON:IBT) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 965.99 and traded as high as GBX 1,145. International Biotechnology shares last traded at GBX 1,115, with a volume of 167,929 shares trading hands.

International Biotechnology Stock Down 0.4%

The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43. The stock has a market cap of £354.88 million, a PE ratio of 4.61 and a beta of 0.32. The business has a 50 day moving average price of GBX 1,022.34 and a 200 day moving average price of GBX 965.99.

International Biotechnology (LON:IBT) last posted its earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. The company had revenue of GBX 24 million for the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%. Equities research analysts expect that International Biotechnology will post 0.9435943 EPS for the current fiscal year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.